Processing

Please wait...

Settings

Settings

1. WO2000040233 - PHARMACEUTICAL COMPOSITION CONTAINING METFORMIN, ACARBOSE OR GLIMEPIRIDE AND OPTIONALLY POLY-(DIMETHYL)-SILOXANE

Publication Number WO/2000/040233
Publication Date 13.07.2000
International Application No. PCT/EP1999/010098
International Filing Date 16.12.1999
Chapter 2 Demand Filed 24.06.2000
IPC
A61K 9/24 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
22Sustained or differential release type
24Layered or laminated unitary dosage forms
A61K 31/64 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
A61K 31/80 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
74Synthetic polymeric materials
80Polymers containing hetero atoms not provided for in groups A61K31/755-A61K31/795112
CPC
A61K 31/155
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines
155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
A61K 31/64
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
A61K 31/702
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A61K 31/80
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
74Synthetic polymeric materials
80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
A61K 9/209
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2072characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
209containing drug in at least two layers or in the core and in at least one outer layer
Applicants
  • HEXAL AG [DE/DE]; Industriestrasse 25 D-83607 Holzkirchen, DE (AllExceptUS)
  • STRÜNGMANN, Thomas [DE/DE]; DE (UsOnly)
Inventors
  • STRÜNGMANN, Thomas; DE
Priority Data
198 60 698.230.12.1998DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND METFORMIN, ACARBOSE ODER GLIMEPIRID UND WAHLWEISE POLY(DIMETHYL)SILOXAN
(EN) PHARMACEUTICAL COMPOSITION CONTAINING METFORMIN, ACARBOSE OR GLIMEPIRIDE AND OPTIONALLY POLY-(DIMETHYL)-SILOXANE
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT DE LA METFORMINE, DE L'ACARBOSE OU DU GLIMERIPIDE ET LE CAS ECHEANT DU POLY(DIMETHYLE)SILOXANE
Abstract
(DE)
Die Erfindung betrifft eine pharmazeutische Zusammensetzung mit verbesserter Wirkung und Verträglichkeit zur Behandlung von Typ-II-Diabetes mellitus, welche eine Kombination von Metformin und/oder dessen pharmazeutisch unbedenklichen Salzen und Glimepirid und/oder Acarbose und wahlweise Poly(dimethyl)siloxan als wirksame Komponenten enthält.
(EN)
The invention relates to a pharmaceutical composition with improved effect and tolerability for the treatment of type II diabetes mellitus. Said composition contains a combination of metformin and/or its pharmaceutically acceptable salts and glimepiride and/or acarbose and optionally poly-(dimethyl)-siloxane as active components.
(FR)
L'invention concerne une préparation pharmaceutique à effet et à tolérabilité améliorés pour traiter le diabète sucré de type II. Cette préparation contient comme constituants actifs une combinaison de metformine et/ou de ses sels pharmaceutiquement tolérables et de glimeripide et/ou d'acarbose et le cas échéant de poly(diméthyle)siloxane.
Also published as
Latest bibliographic data on file with the International Bureau